The healthcare industry has experienced more shortages in the past few years than ever. In addition to prescription drug shortages, the sector has seen shortages in contrast dye and helium, impacting imaging, animal test subjects for...
As the COVID-19 pandemic has progressed over the last three years, the global pharmaceutical landscape has had to evolve to keep up with growing demands. While the worldwide landscape has continued to change and grow, so have the...
The contract development and manufacturing organization (CDMO) Abzena and Pfizer’s CDMO arm CenterOne reached an agreement last week, under which Pfizer will take control of Abzena’s...
Pfizer is investing $750 million to expand its primary manufacturing facility in Kalamazoo, Michigan. The expansion will allow the pharmaceutical company to increase the production of vaccines and...
On October 12, the FDA reported a shortage of amphetamine aspartate, more commonly known as Adderall. This was one of seven shortages reported by the FDA since the beginning of the month, and it joins...
Last week, Merck & Co made the FDA aware of the presence of nitrosamine in its type 2 diabetes drug, Januvia. Merck’s analysis of the drug found nitrosamine levels higher than allowed by the...
In May 2020, Phlow Corp. received $354 million to bring inexpensive generic pharmaceutical manufacturing to the United States. At the time, it was one of the largest coronavirus-era contracts to be...
A former employee of Eli Lilly is suing the company, claiming she was terminated after exposing issues with pharmaceutical manufacturing practices at one United States operation. Amrit Mula said that...
According to the FDA’s enforcement report, Nephron Sterile Compounding Center, in Columbia, South Carolina, is recalling 2,158,351 medical products including syringes and bags because of a lack...
Pharmaceutical giant, Eli Lilly, will extend its operations in Indiana, adding two additional manufacturing facilities with a $2.1 billion investment. Lilly will use the new facilities to produce...
In the United States and worldwide, hospitals are experiencing a shortage of critical iodinated contrast media — also called contrast dye — a nontoxic, contrasting agent that radiologists...
FDA recently sent a warning letter to Medtronic for the headquarters facility of its diabetes business in Northridge, California.
The warning letter focused on the inadequacy of specific medical...
Johnson & Johnson recently announced a potential licensing agreement for its COVID-19 vaccine with Aspen SA Operations (Pty) Ltd, based in South Africa.
The companies will work towards a...
National Resilience recently entered into a multi-year agreement with Moderna to manufacture drug substance mRNA for its COVID-19 vaccine.
Resilience is a manufacturing and technology company...
Premier and 11 top health systems recently acquired a minority stake in Exela Holdings, the holding company of Exela Pharma Sciences, to combat drug shortages in the US.
Participating Premier...
Pfizer and BioNTech recently signed a letter of intent with Eurofarma Laboratoriors SA, a Brazilian pharmaceutical company, to manufacture its COVID-19 vaccine, Comirnaty, in Latin...
Johnson & Johnson will have a new CEO in 2022. Current chairman and CEO Alex Gorsky is transitioning to the role of executive chairman and will be replaced as CEO by Joaquin Duato, according to a...
